Geneos Wealth Management’s Timken Company TKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-107
Closed -$7.76K 3131
2025
Q2
$7.76K Buy
107
+13
+14% +$884 ﹤0.01% 2414
2025
Q1
$6.76K Buy
94
+51
+119% +$3.94K ﹤0.01% 2413
2024
Q4
$3.07K Hold
43
﹤0.01% 2479
2024
Q3
$3.62K Buy
+43
New +$3.54K ﹤0.01% 2159
2024
Q2
Sell
-13
Closed -$1.14K 2175
2024
Q1
$1.14K Buy
+13
New +$1.07K ﹤0.01% 1992
2021
Q3
Sell
-36
Closed -$2K 2906
2021
Q2
$2K Buy
+36
New +$3.05K ﹤0.01% 2688
2018
Q4
Sell
-300
Closed -$14K 2480
2018
Q3
$14K Hold
300
﹤0.01% 1730
2018
Q2
$13K Hold
300
﹤0.01% 1615
2018
Q1
$13K Buy
+300
New +$14.4K ﹤0.01% 1556
2017
Q4
Sell
-407
Closed -$19K 2215
2017
Q3
$19K Hold
407
﹤0.01% 1344
2017
Q2
$18K Hold
407
﹤0.01% 1322
2017
Q1
$18K Hold
407
﹤0.01% 1278
2016
Q4
$16K Hold
407
﹤0.01% 1279
2016
Q3
$14K Hold
407
﹤0.01% 1262
2016
Q2
$12K Sell
407
-163
-29% -$5.47K ﹤0.01% 1279
2016
Q1
$19K Buy
+570
New +$16.5K ﹤0.01% 1109

Other funds holding TKR

Geneos Wealth Management's TKR Position: Q3 2025 in Review

Geneos Wealth Management sold out of Timken Company (TKR) in Q3 2025, closing a stake of 107 shares — an estimated $7.76K sold.

Geneos Wealth Management first reported a position in TKR in Q1 2016 and held it in 16 quarters. The position peaked at $19K in Q3 2017. 430 funds tracked by Wall St. Rank hold TKR as of Q3 2025.

  • Geneos Wealth Management reported no remaining Timken Company position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 107 Timken Company shares in Q3 2025, an estimated $7.76K.
  • Geneos Wealth Management first reported a position in Timken Company in Q1 2016 and held it in 16 quarters.
  • Geneos Wealth Management's Timken Company position peaked at $19K in Q3 2017.
  • 430 funds tracked by Wall St. Rank held Timken Company as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.